Preclinical and clinical technologies pave the way for a novel compound to be developed as a safe and effective treatment.

Aptuit recognizes the importance of these critical steps and provides customers with an integrated network of global resources and an innovative management team experienced in all activities required for submission of a successful IND (exploratory or standard).

We ensure that your product moves beyond preclinical regulatory requirements and gets a significant head start to proof-of-concept and large scale clinical trials.

Our preclinical technology includes:-